Rallybio Corp — insider transactions

8 transactions on record · RLYB · CIK 1739410

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
8
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
2
Bought, 3m
$0
Sold, 3m
$71.5K
Median disclosure lag
3.0 d
trade date to filing date
Largest single trade, 24m
$31.5K
2026-10-26
Director share, 12m
100.0%
of transactions where role is stated
Current run
8 sells
consecutive same-direction transactions
Net 3m flow
-$71.5K
purchases minus sales
Total on record
8

Transactions

8 most recent shown
DisclosedRecorded (UTC)TradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-10-282026-10-29 02:33:23.040 UTC2026-10-262Chung WendyDirectorExercise of derivative2,062$0.00—filing
2026-10-282026-10-29 02:33:23.040 UTC2026-10-262Chung WendyDirectorExercise of derivative2,062$15.28$31.5Kfiling
2026-10-202026-10-21 02:30:22.171 UTC2026-10-164Boudreau Helen MDirectorExercise of derivative2,062$0.00—filing
2026-10-202026-10-21 02:30:22.171 UTC2026-10-164Boudreau Helen MDirectorExercise of derivative2,062$15.28$31.5Kfiling
2026-09-182026-09-19 02:30:36.096 UTC2026-09-162Chung WendyDirectorExercise of derivative3,562$0.00—filing
2026-09-182026-09-19 02:30:36.096 UTC2026-09-162Chung WendyDirectorExercise of derivative3,562$2.38$8.5Kfiling
2026-07-102026-07-26 13:45:41.117 UTC2026-07-064Boudreau Helen MDirectorExercise of derivative3,562$0.00—filing
2026-07-102026-07-26 13:45:41.117 UTC2026-07-064Boudreau Helen MDirectorExercise of derivative3,562$2.38$8.5Kfiling

Source: U.S. Securities and Exchange Commission, EDGAR